Skip to content
10-K

Annual Report

SHENGTAI PHARMACEUTICAL, INC.

0001144204-12-053501

← back to feed
Filed
Sep 28, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Sep 27, 2012 9.58M sh
Capex FY 2012 · Jun 30, 2012 $1.23K
Capex FY 2012 · Jun 30, 2011 $2.02M
Operating Cash Flow FY 2012 · Jun 30, 2012 −$23.74M
Operating Cash Flow FY 2012 · Jun 30, 2011 $5.07M
Short Term Debt FY 2012 · Jun 30, 2012 $73.48M
Short Term Debt FY 2012 · Jun 30, 2011 $48.09M
Cash And Equivalents FY 2012 · Jun 30, 2012 $4.9M
Cash And Equivalents FY 2012 · Jun 30, 2011 $4.05M
Cash And Equivalents FY 2012 · Jun 30, 2010 $4.12M
Stockholders Equity FY 2012 · Jun 30, 2012 $62.33M
Stockholders Equity FY 2012 · Jun 30, 2011 $59.62M
Stockholders Equity FY 2012 · Jun 30, 2010 $49.1M
Current Liabilities FY 2012 · Jun 30, 2012 $110.25M
Current Liabilities FY 2012 · Jun 30, 2011 $84.62M
Current Assets FY 2012 · Jun 30, 2012 $74.02M
Current Assets FY 2012 · Jun 30, 2011 $48.09M
Total Assets FY 2012 · Jun 30, 2012 $172.59M
Total Assets FY 2012 · Jun 30, 2011 $144.24M
Sga Expense FY 2012 · Jun 30, 2012 $11.83M
Sga Expense FY 2012 · Jun 30, 2011 $9.81M
Net Income FY 2012 · Jun 30, 2012 $1.07M
Net Income FY 2012 · Jun 30, 2011 $7.65M
Operating Income FY 2012 · Jun 30, 2012 $5.5M
Operating Income FY 2012 · Jun 30, 2011 $13.32M
Gross Profit FY 2012 · Jun 30, 2012 $17.32M
Gross Profit FY 2012 · Jun 30, 2011 $23.12M
Cost Of Revenue FY 2012 · Jun 30, 2012 $161.71M
Cost Of Revenue FY 2012 · Jun 30, 2011 $148.59M
Revenue FY 2012 · Jun 30, 2012 $179.03M
Revenue FY 2012 · Jun 30, 2011 $171.72M